The prospect of a Danish vaccine against Covid-19 is now one step closer to reality on Monday, when pharmaceutical company Bavarian Nordic presented a bundle of promising data. At the same time, the firm's talks with the Danish government concerning state financial support for the vaccine are progressing well, says Bavarian Nordic Chief Executive Paul Chaplien, reports Danish business daily Børsen.
"Yes, it's taking some time, but I will say the negotiations are going well, they are constructive and are moving forward. We remain confident in achieving financing. We're speaking with the Danish government, but we are also in communication with others. Strong data only helps [the possibility of receiving state funding, -ed.]," Chaplin tells the media.